Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study. (Q46917161)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Aiping Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Qinghe Xing

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Lei Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Lan Yu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Zhiguang Lin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Xingwang Li

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Guoyin Feng

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Lin He

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

1337-1345

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

Risperidone versus haloperidol in psychotic patients with disturbing neuroleptic-induced extrapyramidal symptoms: a double-blind, multi-center trial

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Risperidone plasma levels, clinical response and side-effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Role of monoamine transporters in mediating psychostimulant effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin1A receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Structure and organization of the gene encoding human dopamine transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Association analysis of the dopamine transporter (DAT1)-67A/T polymorphism in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Attention-deficit/hyperactivity disorder (ADHD) association with the DAT1 core promoter -67 T allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Association of the dopamine transporter gene (DAT1) core promoter polymorphism -67T variant with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Antipsychotics and dopamine transporter gene polymorphisms in delirium patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

A comparison of bayesian methods for haplotype reconstruction from population genotype data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Genotype influences in vivo dopamine transporter availability in human striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Meta-analysis shows schizophrenia is not associated with the 40-base-pair repeat polymorphism of the dopamine transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Large-scale single-nucleotide polymorphism (SNP) and haplotype analyses, using dense SNP Maps, of 199 drug-related genes in 752 subjects: the analysis of the association between uncommon SNPs within haplotype blocks and the haplotypes constructed wi

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

The human dopamine transporter gene: the 5'-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Dopamine transporter (SLC6A3) 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Prediction of Dopamine Transporter Binding Availability by Genotype: A Preliminary Report

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.10.1337

10.2217/14622416.8.10.1337

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17979508%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference